Stocks
Meridian Bioscience, Inc.VIVO
NASDAQHealthcareDiagnostics & Research$33.97+0.00%
Price as of · delayed, not real-time
Specializing in diagnostic testing solutions, this company develops and manufactures tests for infectious diseases, gastrointestinal infections, and lead poisoning. Investors monitor its performance due to its niche position in life science tools and recurring revenue from clinical labs.
Market Cap: $1.5B52W Range: $23.44 – $34.38
Congressional Interest in Meridian Bioscience, Inc. (VIVO)
3 members of Congress have disclosed 8 trades in Meridian Bioscience, Inc. (VIVO), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 6 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
8
Unique Politicians
3
Buys
2
Sells
6
Who in Congress Is Trading VIVO?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-02-23 | Tom Malinowski | sell | $1K – $15K |
| 2020-11-13 | Tom Malinowski | sell | $1K – $15K |
| 2020-09-16 | Tom Malinowski | sell | $1K – $15K |
| 2020-09-15 | Tom Malinowski | sell | $1K – $15K |
| 2020-08-31 | Tom Malinowski | sell | $1K – $15K |
| 2015-02-19 | JAMES B. RENACCI | buy | $15K – $50K |
| 2008-12-02 | MICHAEL T. MCCAUL | sell | — |
| 2008-12-02 | MICHAEL T. MCCAUL | buy | — |